Wealth Enhancement Advisory Services, LLC Madrigal Pharmaceuticals, Inc. Transaction History
Wealth Enhancement Advisory Services, LLC
- $55.6 Billion
- Q2 2025
A detailed history of Wealth Enhancement Advisory Services, LLC transactions in Madrigal Pharmaceuticals, Inc. stock. As of the latest transaction made, Wealth Enhancement Advisory Services, LLC holds 701 shares of MDGL stock, worth $209,178. This represents 0.0% of its overall portfolio holdings.
Number of Shares
701Holding current value
$209,178% of portfolio
0.0%Shares
3 transactions
Others Institutions Holding MDGL
# of Institutions
367Shares Held
23.2MCall Options Held
979KPut Options Held
459K-
Janus Henderson Group PLC London, X02.21MShares$658 Million0.42% of portfolio
-
John Paulson Paulson & Co. Inc. | New York, Ny2.1MShares$626 Million39.89% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.02MShares$603 Million10.84% of portfolio
-
Rtw Investments, LP New York, NY1.99MShares$595 Million10.82% of portfolio
-
Baker Bros. Advisors LP New York, NY1.97MShares$589 Million7.8% of portfolio
About MADRIGAL PHARMACEUTICALS, INC.
- Ticker MDGL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 17,103,400
- Market Cap $5.1B
- Description
- Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...